Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections treatment news

Show

From To
UK Gonorrhea Guideline Guards Against Antibiotic Resistance

A new guideline on the management of gonorrhea has been issued by the British Association for Sexual Health and HIV. The 2019 guideline introduced changes made to the 2011 guideline including: removing the recommendation for dual therapy with azithromycin, increasing the dose of ceftriaxone, recommending the use of ciprofloxacin in certain cases, and adding extra-genital testing in cases of known or suspected antimicrobial resistance.

Published
30 January 2019
From
MD Magazine
This Is What It’s Like To Lose Your Local Sexual Health Clinic Under Austerity

In a new series, HuffPost UK is examining how shrinking local budgets are affecting people’s daily lives. These are stories of what it’s like to lose, in a society that is quietly changing.

Published
23 January 2019
From
Huffington Post
Testing times: four emerging STIs that you can’t afford to ignore

Although gonorrhoea, chlamydia and syphilis grab most of the headlines, public health officials are warily watching the emergence of other bacterial sexually transmitted infections.

Published
06 December 2018
From
Mosaic
Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Published
04 September 2018
From
ECDC
'World's worst' super-gonorrhoea man cured

The patient had a lucky escape say doctors, but now two more cases have been discovered.

Published
23 April 2018
From
BBC Health
The recent trend towards multi-resistant gonorrhoea in coastal China

Alarming data have recent been reported (Yin & Chen) (Y&C) from the China Gonococcal Resistance Surveillance Programme (China-GRSP), covering seven (mostly coastal) provinces in the period 2013-2016. The study is relevant for Chinese national treatment policy, which currently recommends azithromycin monotherapy. However, with an estimated 45% of the world’s 78 million incident cases occurring in [...]Read More...

Published
29 March 2018
From
BMJ Group blogs
Gonorrhoea strains across Europe becoming more susceptible to main treatment options

According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging decrease since 2010. However, resistance to one antibiotic agent which is part of the suggested dual therapy of gonorrhoea remains high and threatens the effectiveness of this regimen.

Published
29 August 2017
From
ECDC
Sign-on Letter in Response to Critical Shortage of Penicillin for Syphilis Treatment in U.S.

Sign-on letter to Pfizer urging an immediate response to the nationwide shortage of penicillin G benzathine, the standard treatment for primary and secondary syphilis.

Published
10 July 2017
From
Treatment Action Group
← First1Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.